The era
of guessing
is over.

Pepper Bio makes it possible to develop cures with confidence.

Find new targets. Predict the best patients. And know why it works, before you begin. Applying transomic technology that uses phosphoproteomic data, Pepper partners with your R&D teams. We show you where to start — and just how far you can go.

Discovery is in the data.

Pepper has produced concrete results: proofs of concept and published papers across three therapeutic areas that pave the way for better drug discovery.

Discovery is in the data.

Pepper has produced concrete results: proofs of concept and published papers across three therapeutic areas that pave the way for better drug discovery.

Neurodegenerative

Currently working with a paid industry partner on a drug mechanism of action study.

Publication pending
Oncology

Pre-clinical discovery in untreatable cancers to create a proprietary disease database using transomic data.

Published in Cell Systems (Brubaker, et al., 2019) and Cancer Discovery (Poulin, et al., 2019)
Inflammatory

Pre-clinical validation with an industry partner for indication expansion into IBD from RA.

Published in Integrative Biology (Strasser, et al., 2019) and Science Signaling (Lyons, et al., 2018)
Neurodegenerative

Currently working with a paid industry partner on a drug mechanism of action study.

Publication pending
Inflammatory

Pre-clinical validation with an industry partner for indication expansion into IBD from RA.

Published in Integrative Biology (Strasser, et al., 2019) and Science Signaling (Lyons, et al., 2018)
Oncology

Pre-clinical discovery in untreatable cancers to create a proprietary disease database using transomic data.

Published in Cell Systems (Brubaker, et al., 2019) and Cancer Discovery (Poulin, et al., 2019)

Transomics changes what’s possible.

Global
Capture the full picture of disease biology and drug mechanism with global omics data.
Functional

See the reality of biological processes thanks to proteomic and phosphoproteomic data.

Causative

Understand actual drivers and not just correlation with Pepper’s integrated analysis.

Our platform is the first to use a truly transomic analysis — integrating phosphoproteomics, proteomics, transcriptomics, and genomics. This whole-stack solution to common drug discovery challenges reveals actionable insights others miss.

Transomics changes what’s possible.

Global
Capture the full picture of disease biology and drug mechanism with global omics data.
Functional

See the reality of biological processes thanks to proteomic and phosphoproteomic data.

Causative

Understand actual drivers and not just correlation with Pepper’s integrated analysis.

Our platform is the first to use a truly transomic analysis — integrating phosphoproteomics, proteomics, transcriptomics, and genomics. This whole-stack solution to common drug discovery challenges reveals actionable insights others miss.

Unlock greater commercial opportunities.

Target identification

Patient stratification

Indication expansion

Lead optimization

Drug combinations

Pepper’s solutions identify new possibilities for advancing your business. It’s an engine for reliable, repeatable commercial success.

We’re bridging data, biology, and business.

Samantha Dale
Strasser, PhD

CSO & Co-Founder
PhD, MIT

Samantha develops Pepper’s technology. An NSF Graduate Research Fellow, Churchill Scholar, and Goldwater Scholar, she pioneered omics analysis approaches in Electrical Engineering and Computer Science as well as Biological Engineering at MIT, mentored by Douglas Lauffenburger.

Jon Hu

CEO & Co-Founder
MBA, Harvard Business School

Jon leads Pepper’s business operations. Prior to co-founding Pepper, he served as CEO of enterprise solutions Guild portfolio company Atidiv, where he grew the team from 200 to 300 people, as well as COO of the tech conference Techweek.

Christopher
Nicholson, PhD

Head, Biology
PhD, Newcastle University

Christopher heads Pepper’s research strategy. He was previously a Senior Research Fellow at Harvard Medical School and MGH.

Caitlin Brown, PhD

Head, Business Development
PhD, Brown University

Caitlin heads Pepper's business development. Before joining Pepper, she was a postdoctoral fellow at UMass Medical School and an associate on Cowen's healthcare equity research team.

Mentored by longtime pharma luminaries.

Douglas Lauffenburger, PhD

  • Professor, MIT
  • Founder, Biological Engineering, MIT

Dean Felsher,
MD, PhD

  • Professor, Oncology, Stanford
  • Director, Translational Research,
    Stanford

Imran Nasrullah,
JD

  • VP & Head, Open Innovation Center North America – East, Bayer
  • Former Director, Strategic Partnering
    & Business Development & Licensing, Boehringer-Ingelheim

Tom Rush,
PhD

  • Chief R&D Officer, Variant Bio
  • Former US Lead, Functional Genomics, GlaxoSmithKline

Jerome Windsor,
PharmD

  • SVP, Corporate Development & Product Strategy, GNS Healthcare
  • Former VP, Strategic Accounts and BD, UHG Optum

Peter Hornbeck,
PhD

  • Director, Cell Signaling Technology
  • Founder, PhosphoSitePlus

We’re bridging data, biology, and business.

Samantha Dale Strasser, PhD

CSO & Co-Founder
PhD, MIT

Samantha develops Pepper’s technology.  An NSF Graduate Research Fellow, Churchill Scholar, and Goldwater Scholar, she pioneered omics analysis approaches in Electrical Engineering and Computer Science as well as Biological Engineering at MIT, mentored by Douglas Lauffenburger.

Jon Hu

CEO & Co-Founder
MBA, Harvard Business School

Jon leads Pepper’s business operations. Prior to co-founding Pepper, he served as CEO of enterprise solutions Guild portfolio company Atidiv, where he grew the team from 200 to 300 people, as well as COO of the tech conference Techweek.

Christopher Nicholson, PhD

Head, Biology
PhD, Newcastle University

Christopher heads Pepper’s research strategy. He was previously a Senior Research Fellow at Harvard Medical School and MGH.


Caitlin Brown, PhD

Head, Business Development
PhD, Brown University

Caitlin heads Pepper's business development. Before joining Pepper, she was a postdoctoral fellow at UMass Medical School and an associate on Cowen's healthcare equity research team.

Mentored by longtime pharma luminaries.

Douglas Lauffenburger, PhD

  • Professor, MIT
  • Founder, Biological Engineering, MIT

Dean Felsher, MD, PhD

  • Professor, Oncology, Stanford
  • Director, Translational Research,
    Stanford

Imran Nasrullah, JD

  • VP & Head, Open Innovation Center North America – East, Bayer
  • Former Director, Strategic Partnering
    & Business Development & Licensing, Boehringer-Ingelheim

Tom Rush, PhD

  • Chief R&D Officer, Variant Bio
  • Former US Lead, Functional Genomics, GlaxoSmithKline

Jerome Windsor, PharmD

  • SVP, Corporate Development & Product Strategy, GNS Healthcare
  • Former VP, Strategic Accounts and BD, UHG Optum

Peter Hornbeck, PhD

  • Director, Cell Signaling Technology
  • Founder, PhosphoSitePlus

Join the transomic era of drug discovery.

Contact us to learn how you can work with Pepper. Send us a message, and a member of our team will reach out to you shortly.